Home > Drug Search >
  • company_query: Acasti Pharma
  •   > 
Drug Filter
Category:
chemistry (16) biology (12)
Status:
Approved (2) NDA Filing (2) Phase Ⅲ (6) Phase Ⅱ (12) Phase Ⅰ (6)
Clinical Stage:
Pending (1) Active (23) Discontinued (2)
Bio-Type:
Gene therapy (2) Cell therapy (1) Vaccine (5) Whole antibody (1) Fusion protein (1)
Indication:
Acute myeloid Leukemia (AML) (2) Crohn's disease (1) Hepatic encephalopathy (1) Transplant rejection (1) HBV infection (1) Hypertriglyceridemia (1) Influenza virus infection (2) Insomnia (1) Melanoma (1) Pancreatic cancer (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (2) Solid tumours (1) Spasticity due to multiple sclerosis (1) Rotavirus infection (1) Systemic lupus erythematosus (1) Leber congenital amaurosis (1) Ulcerative colitis (2) Head and neck cancer (1) Ankylosing Spondylitis (AS) (1) Diabetic foot ulcers (1) Age-related macular degeneration (AMD) (1) Pain (2) Stroke (2) Homozygous familial hypercholesterolemia (1) Gram-negative bacterial infection (1) Plaque psoriasis (1) Vasomotor symptoms (1) Bacterial infection (1) Acquired thrombotic thrombocytopenic purpura (1) Dental Caries (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top